Cargando…

Health-Related Quality of Life in Patients with Multiple Sclerosis: Impact of Disease-Modifying Drugs

Multiple sclerosis (MS) has a profound impact on health-related quality of life (HRQoL), a comprehensive subjective measure of the patient’s health status. Assessment of HRQoL informs on the potential advantages and disadvantages of disease-modifying drugs (DMDs) beyond their effects on observer-bas...

Descripción completa

Detalles Bibliográficos
Autor principal:	Jongen, Peter Joseph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511298/ https://www.ncbi.nlm.nih.gov/pubmed/28608280 http://dx.doi.org/10.1007/s40263-017-0444-x

Ejemplares similares

Perspectives and experiences of Dutch multiple sclerosis patients and multiple sclerosis-specialized neurologists on injectable disease-modifying treatment
por: Visser, Leo H, et al.
Publicado: (2016)

A prospective web-based patient-centred interactive study of long-term disabilities, disabilities perception and health-related quality of life in patients with multiple sclerosis in The Netherlands: the Dutch Multiple Sclerosis Study protocol
por: Jongen, Peter Joseph, et al.
Publicado: (2015)

The impact of ocrelizumab on health-related quality of life in individuals with multiple sclerosis
por: Glanz, Bonnie I, et al.
Publicado: (2021)

Glatiramer acetate treatment persistence - but not adherence - in multiple sclerosis patients is predicted by health-related quality of life and self-efficacy: a prospective web-based patient-centred study (CAIR study)
por: Jongen, Peter Joseph, et al.
Publicado: (2017)

Health-related Quality of Life of People with Multiple Sclerosis in Oman
por: Natarajan, Jansirani, et al.
Publicado: (2021)

Health-related quality of life in relapsing remitting multiple sclerosis patients during treatment with glatiramer acetate: a prospective, observational, international, multi-centre study
por: Jongen, Peter J, et al.
Publicado: (2010)

The health-related quality of life of children with multiple sclerosis is mediated by the health-related quality of life of their parents
por: O’Mahony, Julia, et al.
Publicado: (2022)

Role of health-related quality of life measures in the routine care of people with multiple sclerosis
por: Solari, Alessandra
Publicado: (2005)

Impact of Mobility Impairment on Indirect Costs and Health-Related Quality of Life in Multiple Sclerosis
por: Coleman, Craig I., et al.
Publicado: (2013)

Contributing factors to health‐related quality of life in multiple sclerosis
por: Biernacki, Tamás, et al.
Publicado: (2019)

The impact of disease characteristics on multiple sclerosis patients’ quality of life
por: Rezapour, Aziz, et al.
Publicado: (2017)

Disease-modifying drugs for multiple sclerosis and subsequent health service use
por: Ng, Huah Shin, et al.
Publicado: (2021)

Patient decision aid based on multi-criteria decision analysis for disease-modifying drugs for multiple sclerosis: prototype development
por: Kremer, I. E. H., et al.
Publicado: (2021)

The impact of quality of life on treatment preferences in multiple sclerosis patients
por: Lee Mortensen, Gitte, et al.
Publicado: (2017)

Health-related quality of life in multiple sclerosis: temperament outweighs EDSS
por: Salhofer-Polanyi, S., et al.
Publicado: (2018)

Fatigue and health-related quality of life in relapsing-remitting multiple sclerosis after 2 years glatiramer acetate treatment are predicted by changes at 6 months: an observational multi-center study
por: Jongen, Peter Joseph, et al.
Publicado: (2014)

Disease Modifying Therapy in Multiple Sclerosis
por: Williams, U. E., et al.
Publicado: (2014)

Disease-Modifying Drugs for Multiple Sclerosis and Association With Survival
por: Ng, Huah Shin, et al.
Publicado: (2022)

Health economics of disease-modifying therapy for multiple sclerosis in the United States
por: Hartung, Daniel M.
Publicado: (2021)

Oral Disease-Modifying Therapies for Multiple Sclerosis
por: Kim, Woojun, et al.
Publicado: (2015)

When to Initiate Disease-Modifying Drugs for Relapsing Remitting Multiple Sclerosis in Adults?
por: Alkhawajah, Mona, et al.
Publicado: (2011)

Disease-modifying agents in multiple sclerosis
por: Coyle, P. K.
Publicado: (2009)

Voice-Related Quality of Life in Patients with Multiple Sclerosis
por: Hamdan, Abdul Latif, et al.
Publicado: (2012)

Sleep Disorders Reduce Health-Related Quality of Life in Multiple Sclerosis (Nottingham Health Profile Data in Patients with Multiple Sclerosis)
por: Veauthier, Christian, et al.
Publicado: (2015)

Quality of Life in Multiple Sclerosis
por: Williams, Mitchell T., et al.
Publicado: (2020)

The impact of disability, fatigue and sleep quality on the quality of life in multiple sclerosis
por: Ghaem, Haleh, et al.
Publicado: (2008)

Prevalence of cutaneous adverse events associated with long-term disease-modifying therapy and their impact on health-related quality of life in patients with multiple sclerosis: a cross-sectional study
por: Balak, Deepak MW, et al.
Publicado: (2013)

Identification and Prioritization of Important Attributes of Disease-Modifying Drugs in Decision Making among Patients with Multiple Sclerosis: A Nominal Group Technique and Best-Worst Scaling
por: Kremer, Ingrid E. H., et al.
Publicado: (2016)

Impact of disease-modifying therapy on dendritic cells and exploring their immunotherapeutic potential in multiple sclerosis
por: Liu, Caiyun, et al.
Publicado: (2022)

The impact of the comorbid seizure/epilepsy on the health related quality of life in people with multiple sclerosis: an international multicentric study
por: Drulovic, Jelena, et al.
Publicado: (2023)

Safety of Newer Disease Modifying Therapies in Multiple Sclerosis
por: Jalkh, Georges, et al.
Publicado: (2020)

Family health conditions and parental occupational status modify the relationship between pediatric-onset multiple sclerosis and parental health-related quality of life
por: O’Mahony, Julia, et al.
Publicado: (2023)

Multiple Sclerosis: Impact on Oral Hygiene, Dysphagia, and Quality of Life
por: Covello, Francesco, et al.
Publicado: (2020)

Subjective and objective assessment of physical activity in multiple sclerosis and their relation to health-related quality of life
por: Krüger, Theresa, et al.
Publicado: (2017)

Long-term safety and efficacy of natalizumab in relapsing-remitting multiple sclerosis: impact on quality of life
por: Planas, Raquel, et al.
Publicado: (2014)

Validity of Korean Versions of the Multiple Sclerosis Impact Scale and the Multiple Sclerosis International Quality of Life Questionnaire
por: Huh, So-Young, et al.
Publicado: (2014)

Vaccination in multiple sclerosis patients treated with highly effective disease-modifying drugs: an overview with consideration of cladribine tablets
por: Gold, Ralf, et al.
Publicado: (2021)

The Effect of Depression on Health-Related Quality of Life Is Mediated by Fatigue in Persons with Multiple Sclerosis
por: Rodgers, Stephanie, et al.
Publicado: (2021)

Physical and Mental Health–Related Quality of Life Trajectories Among People With Multiple Sclerosis
por: O'Mahony, Julia, et al.
Publicado: (2022)

Adherence to monthly online self-assessments for short-term monitoring: a 1-year study in relapsing-remitting multiple sclerosis patients after start of disease modifying treatment
por: Jongen, Peter Joseph, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_k18deec0a5sdcl80t23a20urfa